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Background: A number of articles addressing various aspects of health-related quality of life (HRQoL) were published
in the Health and Quality of Life Outcomes (HQLO) journal in 2012 and 2013. This review provides a summary of
studies describing recent methodological advances and innovations in HRQoL felt to be of relevance to clinicians
and researchers.
Methods: Scoping review of original research articles, reviews and short reports published in the HQLO journal in 2012
and 2013. Publications describing methodological advances and innovations in HRQoL were reviewed in detail,
summarized and grouped into thematic categories.
Results: 358 titles and abstracts were screened initially, and 16 were considered relevant and incorporated in this
review. Two studies discussed development and interpretation of HRQoL outcomes; two described pediatric HRQoL
measurement; four involved incorporation of HRQoL in economic evaluations; and eight described methodological
issues and innovations in HRQoL measures.
Conclusions: Several studies describing important advancements and innovations in HRQoL, such as the development
of the PROMIS pediatric proxy-item bank and guidelines for constructing patient-reported outcome (PRO) instruments,
were published in the HQLO journal in 2012 and 2013. Proposed future directions for the majority of these studies
include extension and further validation of the research across a diverse range of health conditions.Introduction
Over 350 research articles, reviews and short reports
were published in the Health and Quality of Life Out-
comes (HQLO) journal in 2012 and 2013. Collectively
these publications addressed a broad range of topics in
health-related quality of life (HRQoL) such as alternative
approaches for presenting pooled estimates of patient-
reported outcomes (PROs); parent-proxy reporting and
the Patient-Reported Outcomes Measurement Informa-
tion System (PROMIS) pediatric proxy item bank; mapping
disease-specific instrument scores onto generic measures;
and issues related to evaluating health status changes in
various health conditions. This scoping review aims to pro-
vide a summary of the key advances from the HQLO 2012
and 2013 publications felt to be relevant to researchers and* Correspondence: bradley.johnston@sickkids.ca
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distribution, and reproduction in any mediumclinicians. One reviewer (KB) initially screened all the
titles and the abstracts of the 2012 and 2013 HQLO
publications, and discussed potentially relevant studies
with a second reviewer (BCJ). The full-text publica-
tions were then assessed, and those still considered
relevant were summarized and grouped into one of
four categories discussed in detail below: (1) development
and interpretation of HRQoL outcomes; (2) pediatric
HRQoL measurement; (3) incorporation of HRQoL in
economic evaluations; and (4) methodological issues
and innovations in HRQoL meaures.Development and interpretation of HRQoL outcomes
Conceptual models improve our understanding of a
complex phenomenon such as HRQoL by providing a
schematic representation of a theory and portraying the
inter-relationships between concepts [1]. Differences in
terminology for analogous HRQoL concepts, however,
have made comparisons across studies challenging and
limited the capacity to develop a rigorous body of evi-
dence to guide future HRQoL research and practice [2].ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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common language, Bakas et al. [2] performed a system-
atic review to identify and assess the most frequently ap-
plied HRQoL models over the past ten years. Though
their findings revealed little consensus in the use of
HRQoL models between studies, among those com-
monly applied were the Wilson and Cleary model of
HRQoL, [3] Ferrans and colleagues’ revision of the Wilson
and Cleary model [4] and the World Health Organization
International Classification of Functioning, Disability and
Health (WHO ICF) [5]. Wilson and Cleary’s model com-
bines biomedical and social science paradigms, and con-
sists of 5 related domains: biological, symptoms, function,
general health perception and overall HRQoL. Ferrans
and colleagues’ revision enhances this model by retaining
these domains and adding individual and environmental
characteristics [4]. The WHO ICF model provides a
standard language for health and health states applic-
able across disciplines and cultures, and includes func-
tioning and disability components (e.g. body functioning,
participation) and contextual (environmental and per-
sonal) factors. A critical analysis of the models using
Bredow’s criteria [6] showed that all three were complete
in their descriptions and definitions of HRQoL, and ap-
plicable to real-world settings. The Ferrans and colleagues’
model, however, provided the added benefit of clarity in
conceptual and operational definitions and relationships
among concepts. As such, the authors recommended the
use of the Ferran’s model to improve comparisons of
HRQoL between studies and facilitate the development of
a robust body of evidence for future HRQoL research and
practice.
HRQoL is often measured as a patient-reported out-
come (PRO), described as “any report of the patient’s
health condition that comes directly from the patient
without interpretation of the patient’s response by a clin-
ician or anyone else” [7]. As clinical trials continue to in-
corporate PROs to measure outcomes beyond morbidity
and mortality, systematic reviews and meta-analyses au-
thors contend with the challenge of presenting pooled
PRO estimates. When pooling across different HRQoL
instruments that measure a common construct, the
weighted mean difference is much more challenging to
generate and is replaced with a unitless measure of effect
called the standardized mean difference (SMD). The
publication by Johnston et al. [8] provides an overview
of 5 summary approaches for enhancing the interpret-
ability of pooled PRO estimates: (1) standardized mean
difference (difference in means in each trial divided by
the estimated between-person standard deviation) (2) natural
units (linear transformation of trial data to most familiar
scale) (3) relative and absolute dichotomized effects (propor-
tion above a pre-determined threshold presented as a binary
effect measure) (4) ratio of means (ratio between the meanresponses in the intervention and control group), and
(5) minimal important difference (MID) units (pooled
mean difference presented in MID units, where instead
of dividing the mean difference of each study by its
standard deviation, this method divides by the MID as-
sociated with the PRO measures). When trials all use
the same PRO it is important to report results beyond
a mean difference and statistical significance. When
primary studies have employed more than one instru-
ment it will almost certainly be informative to report
one or more alternatives to the SMD. Calculation and
reporting of several approaches will be reassuring, pro-
vided the estimate of effect is of apparently similar
magnitude; if not, this presents a challenge that re-
viewers should address.Pediatric HRQoL measurement
PROMIS was initiated by the National Institutes of
Health (NIH) in 2004 and was aimed at providing clini-
cians and researchers with important PRO information
not captured by clinical measures, and could also be
used as endpoints in clinical studies evaluating the ef-
fectiveness of treatments for chronic health conditions
[9]. This was achieved by (1) establishing a domain
framework, defined as the structure of a target domain
such as physical health (2) determining the conceptual
framework or hierarchical structure of the domain
(3) developing and validating items that could be grouped
into a set of item banks. The PROMIS pediatric project fo-
cused on developing self-reported PRO item banks among
those aged 8 to 17 years, with a focus on the measurement
of general health domains felt to be important across vari-
ous health states [10] as well as an additional disease-
specific item bank specifically for children with asthma
[11]. In 2010, additional item banks were developed, and
longitudinal validation studies were conducted in new
populations and for new treatment [9]. A pediatric proxy
item bank was developed for those age 5 to 17 years as
part of this initiative, and to address the need for health
status instruments reflecting the perspectives of both the
child and parent in cases where a child is too young, cog-
nitively impaired or unwell to complete a PRO instrument
and a parent proxy report is required [12]. Though proxy
responses are often not equivalent to those provided
directly by a patient, [13-16] it is typically the parents’
perception of their child’s symptoms and outcomes
that influence healthcare utilization [12]. For these rea-
sons, Irwin et al. [10] developed an initial PROMIS
pediatric proxy-report item bank, [17] consisting of
the following five health domains: physical function;
emotional distress; social peer relationships; pain inter-
ference; and asthma impact. The authors acknowledge
that further research is needed to establish construct
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givers of children with chronic health conditions [10].
As mentioned, parent-proxy report can often be a
limitation in the assessment of HRQoL, [18] with only a
few studies evaluating the level of agreement between
parents and children on a child’s HRQoL over time. To ex-
plore this issue further Rajmil et al. [19] conducted a 3-year
sub-study of the European Screening for and promotion of
HRQoL in children and adolescents (KIDSCREEN) project.
The primary focus of the study was to explore the associ-
ation between age and time of follow-up on the level of
agreement, as measured by the KIDSCREEN-27 [20] and
KIDSCREEN-10 [21] questionnaires, between parent and
child on the child’s HRQoL. The analysis showed low
to moderate levels of parent–child agreement at base-
line and lower agreement at follow-up; child’s age and
parent’s self-perceived health were the primary factors
associated with parent–child disagreements over time.
Based on these findings Rajmil et al. recommended
direct self-assessment of HRQoL among children and
adolescents as much as possible, and acknowledge that
their results may have been biased by factors such as
low response rates (54 %) and the generally healthy
characteristics of their study sample.
Incorporation of HRQoL in economic evaluations
In selecting an instrument to measure quality of life
(QoL), its impact on the resulting cost-effectiveness of a
medical intervention should be considered as cost-effect-
iveness is often determined as a cost per quality-adjusted
life year (QALY), a measure combining length of time
with quality of life [22]. Disease-specific instruments are
often preferred over generic ones when measuring QoL as
these tend to focus on specific health problems and are
more sensitive to clinically important differences [23].
Generic measures such as the EuroQOL 5-Dimension
scale (EQ-5D), however, provide a single preference‐based
score that is required for cost‐utility analysis and calcula-
tion of QALYs. One proposed solution to this issue is to
“map” disease‐specific measures onto generic ones using
regression analysis to establish the relationship between
preference-based indices and the dimension or item
scores of disease‐specific measures, thereby obtaining
estimation models that can be used to calculate QALYs
[24,25]. Although a mapping relationship between the
European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire Core 30 (EORTC
QLQ C30) and the utility based values of the EQ 5D
had been previously established, the sample used to
derive these estimates consisted of patients with a sin-
gle type of cancer. Kim et al. [26] aimed to extend this
work to patients with a wide range of cancers in Korea.
The results of the final mapping model demonstrated
reasonable predictive ability, and the authors suggestedthat the resulting mapping algorithm could potentially
inform future cost utility analysis of healthcare inter-
ventions by converting the results of the EORTC QLQ
30 to ED 5D utility indices.
Dakin et al. [27] expanded this work by conducting a
structured literature review aimed at identifying studies
mapping to the EQ-5D. 90 studies reporting 121 map-
ping algorithms had met the study inclusion criteria, of
which 22 involved indirect mapping, and 28 corre-
sponded to musculoskeletal disease. Dakin notes that
the majority of studies were from 2009 to 2012, which
can perhaps be attributed to the publication of the 2008
NICE methods guide for mapping in the absence of dir-
ectly measured EQ-5D [28] and guidance document on
mapping methodology [29]. The publicly available database
of mapping studies is available through: http://www.herc.
ox.ac.uk/downloads/mappingdatabase. Though this data-
base provides researchers with a resource for identify
mapping algorithms linking various instruments with
the EQ-5D, Dakin cautions that no quality assessment
was performed on any of the included studies, and that
mapping should always be considered secondary to direct
EQ-5D measurement, as mapping may introduce add-
itional errors and assumptions.
Both disease‐specific and generic health status instru-
ments can provide important and at times complimentary
insights into the HRQoL of patients affected by chronic
disease and inform the cost effectiveness of different
healthcare interventions [30]. Wilke et al. [31] carried out
a one-year, observational study of patients with advanced
chronic obstructive pulmonary disease to determine
whether and to what extent the scores from a disease spe-
cific questionnaire, the St. George Respiratory Ques-
tionnaire (SGRQ), correlate with generic health status
instruments over time, specifically the EQ-5D; Medical
Outcomes Study 36‐item Short Form Survey (SF-36)
Physical Component Summary Measure (PCS) and
Mental Component Summary Measure (MCS); and the
Assessment of Quality of Life (AQoL) instrument. Pa-
tients completed each of these questionnaires at four
time points (baseline, 4, 8 and 12 months), and the fol-
lowing thresholds used to classify the strength of the
correlation: absent (<±0.20); weak (±0.20 to ±0.34);
moderate (±0.35 to ±0.50); and strong (> ± 0.50) [32].
Correlations between the SGRQ total score and the
scores from each of the generic instruments ranged
from weak to strong at the four time points. At baseline,
the disease-specific and generic health status question-
naires were moderately to strongly correlated, though over
time the correlations between the changes were weak or
absent.
Given the increasing need to use appropriate outcome
measures in health economics research, [33-35] Jones
et al. [22] performed a systematic review to identify the
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ventions involving caregivers of patients with dementia,
and the usefulness of these measures for economic
evaluation. To be considered for inclusion, studies had
to report an intervention with outcome measures for
care providers of persons with dementia such as paid
workers or informal caregivers (e.g. family or friends).
Outcomes for paid workers were included to achieve a
broader indication of which aspects of health and social
care provision are typically measured. Their search iden-
tified 455 articles reporting on 361 studies. Twenty‐nine
studies included details of costs, of which the majority
were only partial economic evaluations that provided
cost‐outcome descriptions (e.g. cost per additional year
that the person with dementia lived at home). Three
studies [36-38] included a cost‐utility analysis using three
generic health measures suitable for QALY calculations:
the EQ‐5D [36], Health Utility Index-2 (HUI2) [37] and
the Caregiver Quality of Life Instrument [38]. Since the
decision to use a specific QoL measure has implications
on its cost-effectiveness, the authors suggest that health
economists select instruments appropriate to their
intended population and outcomes of interest, and
that clinical trialists consider ease of administration,
time constraints, clarity and respondent burden when
choosing an appropriate measure.
Methodological issues and innovations in HRQoL measures
Potential sources of bias when evaluating patient‐reported
outcomes (PROs) include the lack of measurement
equivalence, selection bias and the methods and in-
struments used to evaluate changes in health status.
Measurement equivalence refers to the perception that
individuals from different populations will interpret a
measurement (e.g. PROs) in a conceptually similar man-
ner [39,40]. In cases where an instrument lacks this
property, for instance when study participants may have
different frames of references to respond to questions
about their health, [41,42] between‐group differences
may be confounded by measurement artifact and thus
not reflect true differences in the population. Given the
frequent use of the SF‐36 in over 50 countries [43] and
the lack of studies evaluating its measurement equiva-
lence properties, Lix et al. [39] assessed its measure-
ment equivalence by sex and race using data from the
Canadian Multi-centre Osteoporosis Study (CaMos)
[44]. In brief, CaMos was a prospective cohort study
that aimed to assess the burden, including the health
and economic consequences, of osteoporosis and fracture
among Canadian women and men and identify factors as-
sociated with these conditions [45]. Participants were aged
25 years or older, community‐dwelling, and living within a
50-kilometer radius of a study site [44]. The results of the
confirmatory factor analysis revealed that all forms ofmeasurement equivalence were satisfied for each of the
four groups in this study: Caucasian and non-Caucasian
females; Caucasian and non‐Caucasian males; Caucasian
males and females; and non‐Caucasian males. The study
results further demonstrated that sex and race did not
influence the conceptualization of a general measure
of HRQoL among participants enrolled in the CaMos
study [39].
Selection bias due to non‐response is another issue
when assessing PRO measures, as prior studies have
shown that non-responders have generally poorer health
outcomes when compared to responders [46-50]. In a
study assessing non‐response rates to post‐operative
questionnaires and patient characteristics among National
Health Service (NHS) hospitals in England, Hutchings
et al. [51] found that non-response was significantly asso-
ciated with socio‐demographic and clinical characteristics,
specifically: male gender, younger age, low socio‐economic
status and relatively poor pre‐operative health. The au-
thors emphasize that the implication of their findings de-
pend on the extent to which non‐response is associated
with outcomes, though it is not quite clear whether this
applies to similar observational studies, randomized trials,
or both.
Coste et al. [52] conducted a similar study assessing
the patterns, determinants and impact of non- (missing
forms), incomplete (missing items) and inconsistent
(occurrence of inconsistency between items) responses
on the validity of HRQoL estimates, as measured by
the SF-36, among a representative sample of French
adults participating in the 2003 Decennial Health Sur-
vey (n = 30,782). Several factors were associated with
non and partial responses, of which the strongest were
educational level (lower educational level) and age
(18–25 years or > 50 years); other factors included: oc-
cupation (being economically active), foreign back-
ground, low income (females only), region of residence
(males only), being single, divorced or widowed (males
and females) and morbidity. To evaluate the impact of
non and partial responses on the validity of the
HRQoL estimates, multiple imputation methods were
applied to provide the best-corrected estimates against
which the magnitude of the biases were assessed. This
analysis indicated that the magnitude of the biases
were large among non-responders and several groups
of partial responders, and confirmed a “missing, not-
random” process of missing information in HRQoL
measurement [28]. Consequently, the authors strongly
recommend the use of missing value methods, such as
multiple imputation, to systematically evaluate the conse-
quences of missing and partial responses on HRQoL esti-
mations [29,53,54].
Evaluating changes in health status can also be a chal-
lenging task, as controversy exists regarding the best
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evaluating change in health status for an acute‐onset
condition such as an injury (e.g. fracture, sprain or con-
cussion), pre‐injury health status is often determined in
one of two ways following the event: retrospective evalu-
ation of pre‐injury health, or use of population norms as
a proxy measure for pre-injury health [55]. Wilson et al.
[55] assessed the validity of these two approaches using
EQ-5D data from the Prospective Outcomes of Injury
study (POIS). In this study, participants were asked to
recall their pre-injury (baseline) health at 3 months fol-
lowing the injury, and their current health at 5 and
12 months follow-up. Participants were further classified
as fully recovered or non-recovered based on a self-
assessment of their recovery status at follow-up, and
their scores on the World Health Organization Disability
Assessment Schedule (WHODAS 2.0), an instrument
developed by the World Health Organization (WHO)
used to measure disability [56]. The authors hypothe-
sized that if recalled pre-injury health valuations were
unbiased, then (1) pre-injury health state values would
be statistically similar to post-injury values among those
fully recovered, and (2) pre-injury health state values
would be significantly higher than post-injury values for
those who were non-recovered. Likewise, if population
norms were a valid proxy for pre-injury health then
population norms would approximate the health status
of participants who were fully recovered. Their analysis
showed a small, albeit statistically significant, positive
difference for participants who had fully recovered, and
a large positive difference among those not fully recov-
ered; these differences remained at the two follow-up
time points. In comparing the EQ-5D data with the gen-
eral population, both recovered and non-recovered par-
ticipants reported significantly better pre-injury health
than the population norm. At both follow-up time
points reported health among those who were fully re-
covered remained higher than the general population,
while those who were non-recovered were significantly
lower. These findings showed that both retrospectively
measured pre-injury health status and population norms
differed from those fully recovered from injury. Based
on the magnitude of the differences, Wilson et al. sup-
port the use of retrospective evaluation as these esti-
mates were found to be more precise, though they
caution that there may be a small upward bias with this
approach.
The use of different instruments to assess HRQoL for
a given health condition could potentially result in non-
comparable estimates, which in turn may have an impact
on the cost-effectiveness and health utility of an inter-
vention. This has led some to suggest that for certain
health conditions, one specific instrument to measure
HRQoL may be more appropriate to use than others.Turner et al. [57] evaluated the agreement between, and
suitability of, four different instruments for measuring
health utility in depressed patients: (1) EQ-5D-3 L; (2)
EQ-5D Visual Analog Scale (EQ-5D VAS); (3) SF-6D;
and (4) SF-12 new algorithm. Their findings indicated a
low level of agreement between the four instruments
(overall intra-class correlation (ICC) of 0.57), though
Bland and Altman plots provided evidence that the SF-
6D and SF-12 new algorithm instruments could be used
interchangeably. Plots of the health utility score from
each of the instruments against one another displayed
ceiling and floor effects in the EQ-5D-3 L index scores
and SF-6D and SF-12 new algorithm, respectively, though
all instruments demonstrated responsiveness to change
and had relatively high completion rates. Based on their
results the authors suggest that the SF-12 new algorithm
may be more appropriate for measuring HRQoL than the
EQ-5D-3 L.
Similarly, Kuspinar et al. [58] assessed the extent to
which common generic utility measures such as the
Health Utility Index-2 (HUI2), Health Utility Index-3
(HUI3), EQ-5D and SF-6D capture important and rele-
vant domains for persons with multiple sclerosis (MS),
as missing important domains could contribute to biased
cost-effectiveness analyses due to invalid comparisons
across interventions and populations resulting in in-
accurate QALYs. Of the top 10 domains that the study
sample (n = 185) identified to be most affected by their
MS (work, fatigue, sports, social life, relationships,
walking, cognition, balance, housework and mood),
none of the generic instruments were found to be com-
prehensive: the SF-6D captured 6 domains, followed by
the EQ-5D (4 domains), HUI2 (4 domains) and HUI3
(3 domains). Furthermore, the generic utility measures
included several domains such as pain, self-care, vi-
sion, hearing, manual dexterity, speech and fertility
that were not identified as important by the study sam-
ple. Though imprecise, the authors suggest that the
use of the SF-6D may be the most appropriate to use
among persons with MS compared to other generic
utility measures, and further propose the development
of MS specific “bolt-on” items to generic utility mea-
sures [59], or an MS-specific utility measure consisting
of only disease-specific dimensions.
The term rating scales refers to the response options
within a PRO instrument, and are commonly presented
as a set of categories defined by descriptive labels [60].
In the absence of high quality evidence or general con-
sensus on optimal methods, PRO developers may take
various approaches in constructing a rating scale such as
the use of verbal descriptors to express attitudes (e.g.
strongly disagree, disagree, agree, strongly agree). In de-
veloping these scales certain trade-offs must be taken
into account such as achieving finer discrimination
Table 1 Summary of key issues and corresponding HQLO
references
Key issue Author, year [reference number]
Development & interpretation of
HRQoL outcomes
Bakas T et al., 2012 [2]; Johnston
BC et al., 2013 [8]
Pediatric HRQoL measurement Irwin DE et al., 2012 [10]; Rajmil L
et al., 2013 [19]
Incorporation of HRQoL in
economic evaluations
Jones C et al., 2012 [22]; Kim SH et al.,
2012 [26]; Dakin H, 2013 [27]; Wilke S
et al., 2012 [31]
Methodological issues and
innovations in HRQoL measures
Measurement equivalence Lix M et al., 2012 [42];
Selection bias Hutchings A et al., 2012 [54]; Coste J
et al., 2013 [55]
Evaluating change in health
status
Wilson R et al., 2012 [58]; Turner N
et al., 2013 [60]; Kuspinar A et al.,
2013 [61]; Khadka J et al., 2012 [61];
Krabbe J et al., 2012 [63]
Bandayrel and Johnston Health and Quality of Life Outcomes 2014, 12:110 Page 6 of 9
http://www.hqlo.com/content/12/1/110through more response categories versus respondent bur-
den and capacity to discern between categories, though
there is a lack of clear guidelines to inform this decision.
Khadka et al. [61] aimed to explore the characteristics of
functional and dysfunctional rating scales, and in doing so
develop evidence-based guidelines for constructing rating
scales. Their study sample consisted of adults age 18 years
or older who were on a cataract surgical waiting list in
South Australia. All participants were asked to complete a
package of 10 self-administered PRO measures (rotation-
ally selected from a pool of 17 PRO instruments used to
measure the impact of cataract surgery). Each of the 17
measures assessed various vision-related QoL dimensions
using ratings from four concepts: difficulty (e.g. reading
small print); frequency (e.g. times worrying about worsen-
ing eyesight in past month); severity (e.g. pain or discom-
fort in and around eyes); and global ratings (e.g. global
rating of vision). Based on the results of the Rasch ana-
lysis, a probabilistic mathematical model that estimates
interval measures from ordinal raw data and provides a
strong assessment of rating scale function [62], Khadka
et al. found that items with simple and uniform question
formats and four or five labeled categories were most
likely to be functional and often demonstrated hierarchical
ordering and good coverage of the latent trait under meas-
urement [61]. In contrast, PRO measures with a larger
number of categories and complicated question formats
were likely to have a dysfunctional rating scale. While a
brief summary of the guidelines for developing rating
scales is provided, Khadka et al. emphasize the continuing
need to exercise sound judgment, on the basis of the con-
struct being measured and research question, when devel-
oping a rating scale. The authors further acknowledge that
their study was limited to PRO measures specific to oph-
thalmology, though they note that their work may have
broader relevance and call for its replication in other
disciplines.
Krabbe and Forkman [63] proposed to determine
whether frequency or intensity scales should be employed
as verbal anchors in self-report instruments among pa-
tients with a depressive disorder. Verbal anchors refer to
terms used within a set of statements of a self-report in-
strument indicating the frequency (e.g. never, sometimes,
always) or intensity (e.g. not at all, moderately, extremely)
of the symptoms associated with a specific health condi-
tion [63]. The authors applied three criteria to compare
the appropriateness of using either frequency or intensity
terms: inter-individual congruency of mental representa-
tions of terms; intra-individual stability across time of
mental representations of terms; and distinguishability of
adjacent terms. The authors found that both scales could
be applied as verbal anchors, though they cautioned
against using more than four adjacent terms in a rating
scale, as patients with a depressive disorder may not beable to reasonably distinguish more than four. They fur-
ther suggest the use of frequency-related terms if longitu-
dinal assessment is required, as this study provided
preliminary evidence that terms pertaining to frequency
had slightly higher intra-individual stability over time
compared to those referring to intensity [63].
Conclusion
This scoping review provides a summary of original re-
search articles, reviews and short reports describing
methodological advancements and innovations in QoL
and HRQoL felt to be of significance to clinicians and
researchers and published in the HQLO journal in 2012
and 2013. Of 358 publications, 16 were considered rele-
vant, summarized and grouped into thematic categories
(Table 1).
In summary, two studies were relevant to the develop-
ment and interpretation of HRQoL outcomes. The lit-
erature review by Bakas et al. [2] found little consensus
in the types of HRQoL models used between studies,
and among those that were commonly applied the au-
thors recommended the use of Ferrans and colleagues’
revised model to standardize HRQoL terminology and
improve comparability between studies. In light of the
growing interest in global health and adaptation of PRO
instruments across populations and health conditions,
potential next steps for this research could involve the
application and cross-cultural validation of this model
across geographical areas and health conditions for
which HRQoL has not yet been well assessed.
Johnston et al. [8] provides an overview of five sum-
mary approaches for presenting pooled PRO estimates
when conducting meta-analysis and pooling data across
different HRQoL instruments that measure a common
construct. A proposed next step for this research would
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makers such as clinicians, policy makers and patients
find most useful and easy to understand.
The studies conducted by Irwin et al. [10] and Rajmil
et al. [19] both underscore relatively new concepts in
parent-proxy reporting, and lay the groundwork to ad-
vance this research across a broad range of pediatric-
related health conditions as the samples in these studies
were generally healthy participants.
Four studies pertained to the incorporation of HRQoL
in economic evaluations, two of which described map-
ping disease-specific measures onto generic instruments.
The structured review by Dakin [27] resulted in a data-
base of studies mapping to the EQ-5D, and provided
researchers with an efficient resource for identifying
mapping algorithms. The author notes, however, that
mapping should be considered secondary to direct
measure given the additional errors and assumptions
that this may introduce. Accordingly, a quality assess-
ment of the mapping studies within the database could
enhance this work, which in turn could potentially cre-
ate opportunities for further research in cases where
the quality is found to be sub-optimal.
Eight studies discussed various topics related to meth-
odological issues and innovations in HRQoL measures.
Lix et al. [39] evaluated the measurement equivalence of
the SF-36 in a diverse sample of participants enrolled in
the CaMos trial, and found that sex and race did not in-
fluence the conceptualization of a general measure of
HRQoL. A proposed future direction for this research
would be to replicate this work in other commonly used
generic measures for which measurement equivalence is
yet to be established in comparably diverse populations.
Hutchings et al. [51] and Coste et al. [52] each assessed
aspects of non-response bias on HRQoL estimates and
found that non-response was associated with specific
socio-demographic characteristics such as age and edu-
cation level, and had an impact on the validity of the
HRQoL estimates [52]. While the use of missing value
methods such as multiple imputation as recommended
by Coste [52] has clear implications for future studies, it
would be interesting to see the effect of applying these
methods on prior studies for which this consideration
was not taken into account. Turner et al. [57] and
Kuspiner et al. [58] aimed to determine the extent to
which generic measures included important domains
relevant to depression and MS, respectively. Though
their results showed that none of the generic measures
covered all domains deemed to be important by their
study samples, they recommended the use of the SF-12
new algorithm for depression and SF-6D for MS as these
were found to be the most comprehensive measures
among those currently available. Wilson et al. [55]
assessed the validity of applying population normscompared to retrospective analysis of pre-condition
health among those affected by acute injury, and found
that retrospective evaluation was a less biased measure
of pre-injury health for those fully recovered at one-
year follow-up. Khadka et al. [61] examined the char-
acteristics of functional ratings scales in a sample of
adult participants on a surgical waiting list, and found
that items with simple and uniform question formats
and four or five labeled categories demonstrated function-
ality, hierarchical ordering and good coverage of the
latent trait under measurement. Krabbe and Forkman
[63] assessed whether frequency or intensity scales
should be employed as verbal anchors in PRO mea-
sures in a sample of participants with depressive dis-
order. Their results showed that both types of scales
could be applied as verbal anchors, though they cau-
tioned against using more than four adjacent terms as
this may exceed the capacity for respondents to rea-
sonably distinguish between categories. Given that the
majority of these studies were specific to a particular
health condition, reasonable next steps include the expan-
sion of this research across other health conditions, and as
noted by Kuspinar et al., [58] further developing condition-
specific bolt-on items to generic utility measures and con-
structing utility measures containing only disease specific
dimensions using the guidelines offered by Khadka et al.
[61] and Krabbe and Forkman [63] as appropriate.
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